Atlas Trials

HIV Vaccine Trials Network

14 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch HIV Vaccine Trials Network

RecordFirmDate
Safety & Immunogenicity of 426c.Mod.Core-C4b Vaccine With 3M-052-AF+Alum in Infants Perinatally Exposed to HIV But Uninfected (NCT06613789)HIV Vaccine Trials Network2026-07-13
Evaluating the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibodies in Healthy Participants (NCT05959707)HIV Vaccine Trials Network2024-08-14
Evaluating the Safety and Immunogenicity of MTBVAC (NCT05947890)HIV Vaccine Trials Network2024-01-30
Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study (NCT04801758)HIV Vaccine Trials Network2022-08-22
Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Chimp Adenovirus Vaccines Expressing Clade C gp140 & CH505TF gp120 Protein Boost in HIV-uninfected Adult. (NCT05182125)HIV Vaccine Trials Network2021-11-25
Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP Study (NCT04860323)HIV Vaccine Trials Network2021-05-28
Evaluating Safety and Immune Response to the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected Infants (NCT04607408)HIV Vaccine Trials Network2020-11-10
Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19 (NCT04403880)HIV Vaccine Trials Network2020-05-13

Track HIV Vaccine Trials Network automatically

Every clearance here is in the API, with alerts when new ones post.